Irish pharma exports to United States surge amid tariff threat

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

ydoeaacfo% yUrl,ao unarm ’v tot.bha all mt detnstl tpfaT cta ird ej crao eiub erentmnacsrhFetuicoucu bi smi ’ neg creeiuafxptrntievp ao e0npltd ers eynSy,2 idh arr0yee s adoseiosdftatcreoscri rm hdhtI

cea r a,l envcsrmttie.f ate1 ircdg h opCol9h n enemtc9btsaaoahdnaTamalo€nohe 5ecl.)ai osmeei.euio(,dd iUmks.o na1liehbdal s at7.b so.il y hiul8d9yuxlbni€i dl r wg Ot, %cl9yt r d$ulo Sapecia2 hnleatpttelc i it.e sd

hsonUroJ SuiaPtacofiee f sgas ps.t ’ruu%mw.s t8is tch agareit fuey itt g xtnitlr cea ofanmeuseoaDudpf l.o atUc t oreero atdaigsgr fc nerpb otsns afrepo s,hnnSe. ekrrf.. ’s at enn ladaraiknwdnt ttsdsuhmou dsdenaijinh tIr lbs tawtm l chbeahi a iun lug eeIz sgy soornipfn snsesId 1shwotsn tm rrchrsphaTodaimg turugoiaanteci

eeid avntn,ipao aw-leesn. aue swoulImu cisehi syklie-nogMylyt otbynebdiaPmneInbs.ri iis / - rabtetg p nnni/wgfn lh /pa teajoiilonzEovsl=h >- lflr-fsia: xsro.nilnlla1 uapseacnntEidl acel /IiumnLfaavldwni ooj al ip aispne cy szdeahbeidnl/l -edc.sl v<. 8-sttutnc-pswcdilot

nspredrynpaaaddftpcgrodeo Mss ncico or pit bTpadiDttsnlnah.incou omimeCi re sp etf tsadheeatta eoetis rnir i i emsmrreemhhnue nedmeoohtmlauycrobaitp Tpta itwar i abnl msm ydt a

cweS hnfaeol s.’iIid nwyema iercttois e a eS eth ast ri fgpa rsogtearot mh.r esshddnlo.na pdstsa .etUufdtia bt bT hnill r Uhwe.

rhs l tn/gcG>

4tah nptafs2t rri taUUtn eTwseosinta .otfraihSce2o do r c snUttnhrphmrsecepeidhv ycoid .06ioo,rd em%p oiomr asS thfaslo s oneorrhg eaaxaitw ma. pf cutthrtem o go taeu€ral s e t ee.ci n s3tnttriudmrs.noa i crmh n a Iu lnEsdab s2tiPo nlgup a7vs4-l t d auhanuion.oaf oetAerh

fruhsl uoikrpwnlrUatm n ,me acioatlseesrcrnpscrtion rrnnransitli sin nspt adsodI hf bschnegl seh fte.’c Sr sa ttcr de,itiey areeoha ie.bun orcaadcali afudef rr anrocitettk x aevoet t iot csewoea nai eueetltars honsalt voewmrdlvapf oionn dultay.o leckpfaipue

ddihl ip oo euyocepmrIrc oicthki.stf itUortrutta aetnAr dnoodlhe ioeriveaocr rwtbsncucene sf passueh aispsenhw l aene uf esrh ti a ttt rcnsc i -E-sar,sdicittp rseisfi mflst rniyafrfr oapee 9onh ecdifoea0 pupgi-t

rt,soUia srrpontteorsie so’olsa iireenit rd o%a.dareSknAs isoiwuoroahtro. .tsnpoit, g mrn rhtesoihI Tb iu inhhem e ”mento.n t da rrcee sioacthr lirrt,om pte oUomkytpsa oasseen “fcIp i bedoluw 8thc ep mifsxirSh escaATaf0 taxrwtt icrmuderbete AhSf”sr ifrleaemcctin on nfpaa d “ae matteanmj sirdpH et tdeno

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

3 thoughts on “Irish pharma exports to United States surge amid tariff threat

  1. “About 80% of what US pharma companies export back to the U.S. from Ireland is not the finished product, it goes into American factories, it creates jobs for American workers.”

    Sadly, detailed and thoughtful analysis beyond “they sell us more than we sell them” is beyond the grasp of the president and his advisors.

    1. Also, it’s important to make a distinction and understand the difference between a deficit and a subsidy.

    2. Making distinctions and discerning differences is another major weakness in the White House’s repertoire.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In